Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
Plos One
|
September 22, 2010
Prohibitins are required for cancer cell proliferation and adhesion
Claudia Sievers, Gwendolyn Billig, Kathleen Gottschalk, et al.
Journal of Analytical Toxicology
|
December 2, 2020
Evaluation of Latent Fingerprints for Drug Screening in a Social Care Setting
Caroline Pollard, Claudia Sievers, Paul G Royall, et al.
Vaccine
|
September 19, 2017
Validation of HAV biomarker 2A for differential diagnostic of hepatitis A infected and vaccinated individuals using multiplex serology
Katrin Bohm, Angela Filomena, Nicole Schneiderhan-Marra, et al.
Journal of Clinical Microbiology
|
November 8, 2019
Establishment of a Highly Sensitive Assay for Detection of Hepatitis E Virus-Specific Immunoglobulins
Katrin Bohm, Julia Strömpl, Andi Krumbholz, et al.
Clinical Immunology (Orlando, Fla.)
|
June 5, 2012
Altered microRNA expression in B lymphocytes in multiple sclerosis: towards a better understanding of treatment effects
Claudia Sievers, Maria Meira, Francine Hoffmann, et al.
Experimental Dermatology
|
July 11, 2007
Heme oxygenase-1 inhibits T cell-dependent skin inflammation and differentiation and function of antigen-presenting cells
Joanna Listopad, Khusru Asadullah, Claudia Sievers, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 7, 2014
MiR-126: a novel route for natalizumab action?
Maria Meira, Claudia Sievers, Francine Hoffmann, et al.
Nature Cell Biology
|
July 26, 2005
Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration
Krishnaraj Rajalingam, Christian Wunder, Volker Brinkmann, et al.
Journal of Autoimmunity
|
September 30, 2017
Dimethyl fumarate influences innate and adaptive immunity in multiple sclerosis
Martin Diebold, Claudia Sievers, Glenn Bantug, et al.
Journal of Immunology Research
|
June 6, 2014
Unraveling natalizumab effects on deregulated miR-17 expression in CD4+ T cells of patients with relapsing-remitting multiple sclerosis
Maria Meira, Claudia Sievers, Francine Hoffmann, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
Plos One
|
September 22, 2010
Prohibitins are required for cancer cell proliferation and adhesion
Claudia Sievers, Gwendolyn Billig, Kathleen Gottschalk, et al.
Journal of Analytical Toxicology
|
December 2, 2020
Evaluation of Latent Fingerprints for Drug Screening in a Social Care Setting
Caroline Pollard, Claudia Sievers, Paul G Royall, et al.
Vaccine
|
September 19, 2017
Validation of HAV biomarker 2A for differential diagnostic of hepatitis A infected and vaccinated individuals using multiplex serology
Katrin Bohm, Angela Filomena, Nicole Schneiderhan-Marra, et al.
Journal of Clinical Microbiology
|
November 8, 2019
Establishment of a Highly Sensitive Assay for Detection of Hepatitis E Virus-Specific Immunoglobulins
Katrin Bohm, Julia Strömpl, Andi Krumbholz, et al.
Clinical Immunology (Orlando, Fla.)
|
June 5, 2012
Altered microRNA expression in B lymphocytes in multiple sclerosis: towards a better understanding of treatment effects
Claudia Sievers, Maria Meira, Francine Hoffmann, et al.
Experimental Dermatology
|
July 11, 2007
Heme oxygenase-1 inhibits T cell-dependent skin inflammation and differentiation and function of antigen-presenting cells
Joanna Listopad, Khusru Asadullah, Claudia Sievers, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 7, 2014
MiR-126: a novel route for natalizumab action?
Maria Meira, Claudia Sievers, Francine Hoffmann, et al.
Nature Cell Biology
|
July 26, 2005
Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration
Krishnaraj Rajalingam, Christian Wunder, Volker Brinkmann, et al.
Journal of Autoimmunity
|
September 30, 2017
Dimethyl fumarate influences innate and adaptive immunity in multiple sclerosis
Martin Diebold, Claudia Sievers, Glenn Bantug, et al.
Journal of Immunology Research
|
June 6, 2014
Unraveling natalizumab effects on deregulated miR-17 expression in CD4+ T cells of patients with relapsing-remitting multiple sclerosis
Maria Meira, Claudia Sievers, Francine Hoffmann, et al.
Page
of 3